Piggybacking and IOL is a successful technique

Article

Piggybacking with the Add-On IOL is safe, efficient and reliable for correcting pseudophakic refractive errors.

Piggybacking with the Add-On IOL is safe, efficient and reliable for correcting pseudophakic refractive errors.

A team led by Dr B. Basarir, Beyoglu Eye Education and Research Hospital, Istanbul, Turkey, included 10 eyes of 10 patients with pseudophakic refractive errors. All patients were targeted to achieve a range of refraction between -0.50 to +0.50 D.

Preoperative and postoperative outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), endothelial cell count (ECC), anterior chamber depth (ACD), the distance between intraocular lenses and contrast sensitivity measurements under mesopic, scotopic, and scotopic with glare conditions.

The mean preoperative and postoperative UDVA was 0.133±0.12 and 0.73±0.27, respectively. Mean preoperative and postoperative CDVA were 0.77±0.26 and 0.79±0.27, respectively.

The findings revealed the mean preoperative and postoperative ACD to be 3.87±0.91 mm vs. 3.58±1.05 mm, respectively. All patients achieved the target refractive range of -0.50 D to +0.50 D and no complications were recorded.

The abstract, recently published in the European Journal of Ophthalmology can be found here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.